According to Zhitong Finance App News, Peger Biopharmaceutical-B (02565.HK) announced that the core innovative drug product Vipenatide injection (trade name: Pidacan®, hereinafter referred to as “Pidacan®”) was successfully included in the “2026 National Basic Medical Insurance, Maternity Insurance and Work Injury Insurance Drug Catalogue” recently announced by the National Health Security Administration.

Zhitongcaijing · 1d ago
According to Zhitong Finance App News, Peger Biopharmaceutical-B (02565.HK) announced that the core innovative drug product Vipenatide injection (trade name: Pidacan®, hereinafter referred to as “Pidacan®”) was successfully included in the “2026 National Basic Medical Insurance, Maternity Insurance and Work Injury Insurance Drug Catalogue” recently announced by the National Health Security Administration.